11. High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomasIvana Jovchevska, Alja Zottel, Neja Šamec, Jernej Mlakar, Maxim Sorokin, Daniil Nikitin, Anton A. Buzdin, Radovan Komel, 2019, original scientific article Keywords: glioblastoma, malignancy, FREM2, SPRY1, TCGA Full text (file, 5,25 MB) This document has more files! More... |
12. Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidatesMarko Vidak, Ivana Jovchevska, Neja Šamec, Alja Zottel, Mirjana Liović, Damjana Rozman, Sašo Džeroski, Peter Juvan, Radovan Komel, 2018, original scientific article Keywords: glioblastoma, glioblastoma stem cells, biomarkers, data repositories, meta-analysis, cell surface, experimental validation, FREM2, SPRY1 Full text (file, 9,34 MB) This document has more files! More... |
|
14. Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivoAlja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovchevska, 2023, original scientific article Keywords: glioblastoma, vimentin, nanobody, invasion, EMT Full text (file, 2,42 MB) This document has more files! More... |
|